ClinicalTrials.gov
public full text
Public Domain
REcycled CartiLage Auto/Allo IMplantation
This is an FDA phase I study to evaluate the safety of allogeneic culture-expanded adipose-derived mesenchymal stem cells (AMSCs) combined with autologous cartilage cells to treat focal knee cartilage defects in one stage surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis#895940
- Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair#852499
- Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).#854421
- Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects#1046711
- Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.#867660
Record · ID 854250
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive